India's CRDMO sector, projected to hit $22-25 billion by 2035, is rapidly expanding due to cost advantages and quick startup ...

Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced today that it has completed its previously announced ...

Dr. Drew Weissman warns that a rise in anti-vaxxers could lead to deaths from preventable diseases like measles and polio, ...

A GROUNDBREAKING cancer vaccine reversed the disease in nine patients, a study has shown. They remained disease free three ...

This surge is also being driven by India's cost advantages compared to Western countries, 90 per cent faster project startup ...

The scientists demonstrate that it is possible to specifically deliver the treatment to the muscle stem cells, avoiding ...

The Indian Contract Research, Development, and Manufacturing Organization (CRDMO) sector is expected to touch USD 22 billion ...

Our Bureau, Bengaluru Tuesday, February 25, 2025, 15:15 Hrs [IST] ...

India's CRDMO sector is set to reach USD 22-25 billion by 2035, driven by cost advantages and rapid project startups, according to a BCG and IPSO report. India is emerging as a preferred outsourcing ...

The scientists found that HSV-1 activates transposable elements that impact the accumulation of Alzheimer's-linked proteins ...

As part of this partnership, Lucence’s molecular testing solutions will be incorporated into Agilus’ oncology diagnostics ...